| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 15634273 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 341 journal articles in the PubMed database | Email to a friend | | |
| Eriksson BI, Dahl OE, Büller HR, et al.
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Thromb Haemost 2005 Jan; 3(1):103-11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Eriksson BI, Dahl OE, Ahnfelt L, et al.
Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I. [Clinical Trial, Journal Article, Multicenter Study]
J Thromb Haemost 2004 Sep; 2(9):1573-80.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Eriksson BI, Dahl OE, Rosencher N, et al.
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. [Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Lancet 2007 Sep 15; 370(9591):949-56.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Eriksson BI, Dahl OE, Rosencher N, et al.
Dabigatran etexilate versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. [JOURNAL ARTICLE]
J Thromb Haemost 2007 Aug 24.
Abstract | Full Citation | Find Related Articles | | Colwell CW, Berkowitz SD, Davidson BL, et al.
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial]
J Thromb Haemost 2003 Oct; 1(10):2119-30.
Abstract | Full Citation | Find Related Articles | | Eriksson BI, Agnelli G, Cohen AT, et al.
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Thromb Haemost 2003 Dec; 1(12):2490-6.
Abstract | Full Citation | Find Related Articles | | Agnelli G, Haas S, Ginsberg JS, et al.
A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement. [Journal Article]
J Thromb Haemost 2007 Apr; 5(4):746-53.
Abstract | Full Citation | Find Related Articles | | Eriksson BI, Bergqvist D, Kälebo P, et al.
Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Lancet 2002 Nov 9; 360(9344):1441-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Evans HC, Perry CM, Faulds D
Ximelagatran/Melagatran: a review of its use in the prevention of venous thromboembolism in orthopaedic surgery. [Journal Article, Review]
Drugs 2004; 64(6):649-78.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
